Navigation Links
New FDA regulations puts some cough syrups off market

The Food and Drug Administration's(FDA) new effort to re-examine very old drugs that began selling before the government ever required proof that drugs worked well, has landed dozens of brands of prescription cough syrup in trouble. Until now FDA stressed that the expectorant, extended-release guaifenesin, is not dangerous. However, the recent crackdown lead to the FDA formally approving sale of Adams// Laboratories' Mucinex, making competing companies' unapproved versions automatically illegal. The FDA has warned 66 manufacturers that Mucinex would be the only once-a-day prescription guaifenesin allowed to sell unless its competitors won formal approval. The FDA has given these companies time till end of November to pull their brands of extended-release guaifenesin off the market.


'"/>




Page: 1

Related medicine news :

1. Avenues to opened for medical tourists following relaxation of visa regulations
2. Hostility breeds against Homeopathy in England following new regulations
3. Negligent doctors asked to cough up 3 lakhs for death of patient
4. Iron supplements proves helpful in dry cough .
5. Hypertensive drugs may cause cough
6. Sensitive cough suffered by females
7. How to arrest cough
8. Chronic cough can lead to depression
9. High Incidence of Whooping cough
10. Australia coughs up $15m to resurrect Lebanon
11. Indias anti-AIDS drug market engaged in price war
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... Sparks, Nevada (PRWEB) , ... May 26, 2017 ... ... to produce the first ever copper, antimicrobial, mesh back 24/7 task chair specifically ... and conference applications. “We are thrilled to partner with Cupron® to provide ...
(Date:5/26/2017)... Texas (PRWEB) , ... May 26, 2017 , ... Yisrayl ... a new publication this week that is focusing on the Peace Agreements being discussed ... his Middle East sprint in a race to try to speed up peace talks ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
(Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
Breaking Medicine Technology: